Ultravate (Ranbaxy Laboratories, Inc.)


Welcome to the PulseAid listing for the Ultravate drug offered from Ranbaxy Laboratories, Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ranbaxy Laboratories, Inc.
NON-PROPRIETARY NAME: halobetasol propionate
SUBSTANCE NAME: HALOBETASOL PROPIONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: TOPICAL
DOSAGE FORM: LOTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-03-01
END MARKETING DATE: 0000-00-00


Ultravate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionUltravate from Ranbaxy Laboratories, Inc.
LABELER NAME: Ranbaxy Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/g)
START MARKETING DATE: 2016-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10631-122_1e0e23af-03ba-4520-ab13-7544e0c6a7f1
PRODUCT NDC: 10631-122
APPLICATION NUMBER: NDA208183

Other HALOBETASOL PROPIONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc.Halobetasol Propionate
G&W Laboratories, Inc.Halobetasol Propionate
H.J. Harkins Company, Inc.Halobetasol Propionate
Perrigo New York IncHalobetasol Propionate
Physicians Total Care, Inc.Halobetasol Propionate
Ranbaxy Laboratories Inc.Ultravate
Ranbaxy Laboratories, Inc.Ultravate
Rebel Distributors CorpHalobetasol Propionate
Taro Pharmaceuticals U.S.A., Inc.Halobetasol Propionate